Airway subepithelial fibrosis in a murine model of atopic asthma: Suppression by dexamethasone or anti-interleukin-5 antibody

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 2, 2000, Pages 241-246

  Blyth, David I ^a   Wharton, Tsumi F ^a   Pedrick, Michael S ^a   Savage, Tony J ^a   Sanjar, Shahin ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE;

EID: 0033840582     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.2.3999     Document Type: Article

References (42)

1. 1. Beasley, R., C. Burgess, J. Crane, N. Pearce, and W. Roche. 1993. Pathology of asthma and its clinical implications. J. Allergy Clin. Immunol. 92:148-154.
2. 2. Awadh, N., N. L. Müller, C. S. Park, R. T. Abboud, and J. M. Fitzgerald. 1998. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 53:248-253.
3. 3. Dunnill, M. S. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
4. 4. Jeffery, P. K., A. J. Wardlaw, F. C. Nelson, J. V. Collins, and A. B. Kay. 1989. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am. Rev. Respir. Dis. 140:1745-1753.
5. 5. Jeffery, P. K. 1992. Histological features of the airways in asthma and COPD. Respiration 59 (Suppl. 1):13-16.
6. 6. Orsida, B. E., X. Li, B. Hicker, F. Thien, J. W. Wilson, and E. H. Walters. 1999. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 54:289-295.
7. 7. Rogers, D. F., and T. W. Evans. 1992. Plasma exudation and oedema in asthma. Br. Med. Bull. 48:120-134.
8. 8. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
9. 9. Hoshino, M., Y. Nakamura, J. J. Sim, J. Shimojo, and S. Isogai. 1998. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol. 102:783-788.
10. 10. Brewster, C. E. P., P. H. Howarth, R. Djukanovic, J. Wilson, S. T. Holgate, and W. R. Roche. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3:507-511.
11. 11. Gizycki, M. J., E. Ädelroth, A. V. Rogers, P. M. O'Byrne, and P. K. Jeffery. 1997. Myofibroblast involvement in allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell Mol. Biol. 16:664-673.
12. 12. James, A. L., P. D. Paré, and J. C. Hogg. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139:242-246.
13. 13. Blyth, D. I., M. S. Pedrick, T. J. Savage, E. M. Hessel, and D. Fattah. 1996. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14:425-438.
14. 14. Unsworth, D. J., D. L. Scott, T. J. Almond, H. K. Beard, E. J. Holborow, and K. W. Walton. 1982. Studies on reticulin: I. Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin. Br. J. Exp. Pathol. 63:154-166.
15. 15. Blyth, D. I., M. S. Pedrick, T. J. Savage, H. Bright, J. E. Beesley, and S. Sanjar. 1998. Induction, duration and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am. J. Respir. Cell Mol. Biol. 19:38-54.
16. 16. Blyth, D. I., M. S. Pedrick, and S. Sanjar. 1998. The severity of airway inflammation and goblet cell hyperplasia in a murine model of atopic asthma are directly related to allergen dose and are reduced by treatment with a glucocorticoid. J. Pharm. Pharmacol. 50(Suppl):70. (Abstr.)
17. 17. Gordon, H., and H. H. Sweets. 1936. A simple method for the silver impregnation of reticulum. Am. J. Pathol. 12:545-552.
18. 18. Weibel, E. R. 1966. Practical stereological methods of morphometric cytology. J. Cell Biol. 30:23. (Abstr.)
19. 19. Howard, C. V., and M. G. Reed. 1998. Unbiased Stereology: Three-Dimensional Measurement in Microscopy. Bios Scientific Publishers Ltd., Oxford, UK. 198.
20. 20. Garlisi, C. G., T. T. Kung, P. Wang, M. Minnicozzi, S. P. Umland, R. W. Chapman, D. Stelts, Y. Crawley, A. Falcone, J. G. Myers, H. Jones, M. M. Billah, W. Kreutner, and R. W. Egan. 1999. Effects of anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 20:248-255.
21. 21. Djukanović, R., C. K. W. Lai, J. W. Wilson, K. M. Britten, S. J. Wilson, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur. Respir. J. 5:538-544.
22. 22. Chu, H. W., J. L. Halliday, R. J. Martin, D. Y. M. Leung, S. J. Szefler, and S. E. Wenzel. 1998. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am. J. Respir. Crit. Care Med. 158:1936-1944.
23. 23. Chetta, A., A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, and D. Olivieri. 1997. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111:852-857.
24. 24. Boulet, L.-P., M. Laviolette, H. Turcotte, A. Cartier, M. Dugas, J.-L. Malo, and M. Boutet. 1997. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112:45-52.
25. 25. Hoshino, M., Y. Nakamura, and J. J. Sim. 1998. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 53:21-27.
26. 26. Chakir, J. C., M. Laviolette, M. Boutet, R. Laliberté, J. Dubé, and L.-P. Boulet. 1996. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab. Invest. 75:735-744.
27. 27. Pohunek, P., W. R. Roche, J. Turzikova, J. Kurdman, and J. O. Warner. 1997. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur. Respir. J. 10:160s. (Abstr.)
28. 28. Warner, J. O., J. A. Warner, P. Pohunek, R. Rao, C. Marquet, J. B. Clough, and W. R. Roche. 1998. Markers of allergy and inflammation. Pediatr. Allergy Immunol. 9(Suppl. 11):53-57.
29. 29. Warner, J. O., C. Marquet, R. Rao, W. R. Roche, and P. Pohunek. 1998. Inflammatory mechanisms in childhood asthma. Clin. Exp. Allergy 28(Suppl. 5): 71-75.
30. 30. Laurent, G. J. 1991. Regulation of lung collagen production during wound healing. Chest 99:67S-69S.
31. 31. Wilson, J. W., and X. Li. 1997. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin. Exp. Allergy 27:363-371.
32. 32. Wiggs, B. R., C. A. Hrousis, J. M. Drazen, and R. D. Kamm. 1997. On the mechanism of mucosal folding in normal and asthmatic airways. J. Appl. Physiol. 83:1814-1821.
33. 33. Saetta, M., P. Maestrelli, G. G. Turato, C. E. Mapp, G. Milani, F. Pivirotto, L. M. Fabbri, and A. D. Stefano. 1995. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J. Respir. Crit. Care Med. 151:489-494.
34. 34. Trigg, C. J., N. D. Manolitsas, J. Wang, M. A. Calderón, A. McAulay, S. E. Jordan, M. J. Herdman, N. Jhalli, J. M. Duddle, S. A. Hamilton, J. L. Devalia, and R. J. Davies. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 150:17-22.
35. 35. Hoshino, M., Y. Nakamura, J. J. Sim, Y. Yamashiro, K. Uchida, K. Hosaka, and S. Isogai. 1998. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor expression in bronchial asthma. Clin. Exp. Allergy. 28:568-577.
36. 36. Olivieri, D., A. Chetta, M. Del Donno, G. Bertorelli, A. Casalini, A. Pesci, R. Testi, and A. Foresi. 1997. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am. J. Respir. Crit. Care Med. 155:1864-1871.
37. 37. Foster, P. S., S. P. Hogan, A. J. Ramsey, K. I. Matthaei, and I. G. Young. 1996. Interleukin-5 deficiency abolishes cosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
38. 38. Temelkovski, J., S. P. Hogan, D. P. Shepherd, P. S. Foster, and R. K. Kumar. 1998. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53:849-856.
39. 39. Lee, J. J., M. P. McGarry, S. C. Farmer, K. L. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, G. D. Leikauf, and N. A. Lee. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143-2156.
40. 40. Temann, U.-A., G. P. Geba, J. A. Rankin, and R. A. Flavell. 1998. Expression of interleukin-9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188:1307-1320.
41. 41. Tang, W., G. P. Geba, T. Zheng, P. Ray, R. J. Homer, C. Kuhn, R. A. Flavell, and J. A. Elias. 1996. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J. Clin. Invest. 98:2845-2853.
42. 42. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang. and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis. physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779-788.